Evidence map›Paper›PMID 21594967›Full record

ReviewLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2011

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma.

Josep M Llovet, Valerie Paradis, Masatoshi Kudo, Jessica Zucman-Rossi

Abstract readReview
In one paragraph

Review in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Josep M LlovetBarcelona Clinic Liver Cancer Group, Hospital Clínic, Network Center for Biomedical Research in Hepatic and Digestive Diseases, August Pi i Sunyer Institute for Biomedical Research, Barcelona, Spain. jmllovet@clinic.ub.es
Valerie Paradis
Masatoshi Kudo
Jessica Zucman-Rossi

Funding

Integrative genomic analysis in hepatocellular carcinomaR01DK076986 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LLOVET, JOSEP M · 2007 to 2011
$1.3M
NIDDK NIH HHS R01 DK076986
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Liver TransplantationPatient SelectionAntineoplastic AgentsBiomarkers, TumorCarcinoma, HepatocellularDecision Support TechniquesEvidence-Based MedicineHumansLiver NeoplasmsMolecular Targeted TherapyPredictive Value of TestsPrognosisAntineoplastic AgentsBiomarkers, Tumor

Identifiers

PMID21594967
PMCPMC3164216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.